US Bancorp’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$429K Sell
28,996
-2,806
-9% -$41.5K ﹤0.01% 1586
2025
Q1
$570K Buy
31,802
+7
+0% +$125 ﹤0.01% 1396
2024
Q4
$554K Buy
31,795
+24,286
+323% +$423K ﹤0.01% 1444
2024
Q3
$105K Sell
7,509
-100
-1% -$1.4K ﹤0.01% 2377
2024
Q2
$62.5K Buy
7,609
+6,691
+729% +$55K ﹤0.01% 2546
2024
Q1
$7.08K Buy
918
+303
+49% +$2.34K ﹤0.01% 3422
2023
Q4
$5.53K Buy
615
+541
+731% +$4.86K ﹤0.01% 3490
2023
Q3
$662 Hold
74
﹤0.01% 3797
2023
Q2
$1.14K Sell
74
-294
-80% -$4.52K ﹤0.01% 3758
2023
Q1
$8.28K Buy
368
+294
+397% +$6.61K ﹤0.01% 3335
2022
Q4
$1.56K Sell
74
-33
-31% -$694 ﹤0.01% 3822
2022
Q3
$3K Buy
107
+6
+6% +$168 ﹤0.01% 3740
2022
Q2
$2K Sell
101
-1,386
-93% -$27.4K ﹤0.01% 3860
2022
Q1
$38K Buy
1,487
+1,386
+1,372% +$35.4K ﹤0.01% 2752
2021
Q4
$3K Hold
101
﹤0.01% 3801
2021
Q3
$2K Sell
101
-26
-20% -$515 ﹤0.01% 3884
2021
Q2
$2K Buy
127
+26
+26% +$409 ﹤0.01% 3826
2021
Q1
$3K Hold
101
﹤0.01% 3612
2020
Q4
$3K Hold
101
﹤0.01% 3494
2020
Q3
$2K Sell
101
-76
-43% -$1.51K ﹤0.01% 3454
2020
Q2
$4K Sell
177
-134
-43% -$3.03K ﹤0.01% 3324
2020
Q1
$5K Hold
311
﹤0.01% 3202
2019
Q4
$5K Buy
311
+101
+48% +$1.62K ﹤0.01% 3235
2019
Q3
$2K Buy
210
+76
+57% +$724 ﹤0.01% 3443
2019
Q2
$3K Buy
134
+32
+31% +$716 ﹤0.01% 3405
2019
Q1
$2K Buy
+102
New +$2K ﹤0.01% 3440
2018
Q4
Sell
-47
Closed -$1K 3698
2018
Q3
$1K Hold
47
﹤0.01% 3584
2018
Q2
$1K Buy
+47
New +$1K ﹤0.01% 3570